COMMUNIQUÉS West-GlobeNewswire

American Health Council Honors Paul M. Colombani, MD, FACS, FAAP as “Best in Medicine”
22/11/2017
NEW YORK, Nov. 22, 2017 (GLOBE NEWSWIRE) -- Dr. Paul M. Colombani, Chairman of the Pediatric Surgery at Johns Hopkins All Children's Hospital, Professor of Surgery, Pediatrics and Oncology at the Johns Hopkins [...]
DiaMedica Therapeutics Announces Ethics Committee Clearance at First Site to Initiate REMEDY Phase 2 Trial for Acute Ischemic Stroke
22/11/2017
MINNEAPOLIS, Nov. 22, 2017 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (the “ Company ”) (TSX Venture:DMA) (OTCQB:DMCAF), announced it has received ethics committee approval to initiate the first clinical site for [...]
Athenex to Present at 29th Annual Piper Jaffray Healthcare Conference
22/11/2017
BUFFALO, N.Y., Nov. 22, 2017 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq: ATNX ), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]
Soleno Therapeutics to Present at the Piper Jaffray 29th Annual Healthcare Conference
22/11/2017
REDWOOD CITY, Calif., Nov. 22, 2017 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (NASDAQ: SLNO ), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today [...]
Transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associated parties
22/11/2017
Valby, Denmark, 2017-11-22 13:56 CET (GLOBE NEWSWIRE) -- Valby, Denmark, 22 November 2017 – H. Lundbeck A/S (Lundbeck) hereby publishes and reports transactions made by executives and persons closely associated with [...]
Kalytera Announces $5 Million Private Placement of Convertible Debenture Units
22/11/2017
/NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES/ SAN FRANCISCO and TEL AVIV, Israel, Nov. 22, 2017 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE:KALY) (OTCQB:KALTF) (the " [...]
Bavarian Nordic A/S - Articles of Association
22/11/2017
Updated Articles of Association for Bavarian Nordic A/S Attachments: http://www.globenewswire.com/NewsRoom/AttachmentNg/849cc51c-d3fb-4aba-8ee9-521a3ab2adcc
Otonomy to Present at Piper Jaffray Healthcare Conference
22/11/2017
SAN DIEGO, Nov. 22, 2017 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC ), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the ear, [...]
Cesca Therapeutics Appoints Healthcare Investment Banking Veteran Joe E. Balagot as Senior Vice President of Corporate Development
22/11/2017
RANCHO CORDOVA, Calif., Nov. 22, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ: KOOL ), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced the [...]
Summit Therapeutics to Participate in Upcoming Investor Conferences
22/11/2017
Summit Therapeutics plc ("Summit", or the "Company") SUMMIT THERAPEUTICS TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES Oxford, UK, 22 November 2017- Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM), the drug [...]
Preferred Dental Technologies Announces 3D Technology Breakthrough that brings its Game Changing Technology to the Forefront
22/11/2017
WINNIPEG, Manitoba, Nov. 22, 2017 (GLOBE NEWSWIRE) -- Preferred Dental Technologies Inc. ( “ Company ”) (CSE:PDT) announces 3D Technology Breakthrough that brings its game changing technology to the forefront. The [...]
GW Pharmaceuticals to Present at Upcoming Investor Conferences
22/11/2017
– 29th Annual Piper Jaffray Healthcare Conference on November 29, 2017 – – Evercore ISI 2017 Biopharma Catalyst/Deep Dive Conference on November 30, 2017 – LONDON, Nov. 22, 2017 (GLOBE NEWSWIRE) -- GW Pharmaceuticals [...]
REGENXBIO to Present at Upcoming Investor Conferences
22/11/2017
ROCKVILLE, Md., Nov. 22, 2017 (GLOBE NEWSWIRE) -- REGENXBIO Inc. (Nasdaq: RGNX ), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its [...]
Summit Therapeutics to Participate in Upcoming Investor Conferences
22/11/2017
OXFORD, United Kingdom, Nov. 22, 2017 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ: SMMT ) (AIM:SUMM), the drug discovery and development company advancing therapies for Duchenne muscular dystrophy (‘DMD’) and [...]
Evogene Reports Third Quarter 2017 Financial Results
22/11/2017
REHOVOT, Israel, Nov. 22, 2017 (GLOBE NEWSWIRE) -- Evogene Ltd. (NASDAQ: EVGN ) (TASE: EVGN ), a leading biotechnology company developing novel products for life science markets through the use of a unique computational [...]
Pluristem Granted Key U.S. Patent for Skeletal Muscle Regeneration - a Meaningful Asset Ahead of Upcoming Phase III Femoral Neck Fracture Study
22/11/2017
Patent relates to the use of Mesenchymal Stem Cells (MSCs) for muscle regeneration following muscle injury Pivotal Phase III study to take place in U.S. and Europe to support recovery from hip fracture HAIFA, Israel, [...]
Avivagen Announces the Appointment of Mr. Aubrey Dan to the Board of Directors
22/11/2017
OTTAWA, Nov. 22, 2017 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (Avivagen or the Corporation), a life sciences innovation company with a series of patent protected products that support and optimize [...]
RadNet, Inc. to Present at the Bank of America Merrill Lynch 2017 Leveraged Finance Conference on November 29, 2017
22/11/2017
LOS ANGELES, Nov. 22, 2017 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT ), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient [...]
Gemphire to Present at the Piper Jaffray and LD Micro Investor Conferences
22/11/2017
LIVONIA, Mich., Nov. 22, 2017 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ: GEMP ), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders [...]

Pages